Not Tagged
Not Tagged
['mmsm', '#162', 'fil,veral,12', '1920', 'alnuctamab']
congress | #ash22
sandy wong , reports phase i data for the 2+1 bcmaxcd3 t-cell engager alnuctamab. in heavily pretreated rrmm, sc alnuctamab orr = 53% &amp; median time to response = 1 month. sc improved safety profile vs iv, allowing higher doses. #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma